Rapid point of Care Diagnostics to Determine Cytomegalovirus Infection
$222,693N43FY2017AINIH
Zymeron Corporation, Durham NC
Investigators
Abstract
To develop a point-of-care test to measure the IgG and IgM antibodies from human blood and to determine the serostatus of CMV infection.
View original record on NIH RePORTER →